High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 51, Issue 1, Pages 180-190
Publisher
Wiley
Online
2020-12-02
DOI
10.1002/eji.202049058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
- (2020) Ruiyun Li et al. SCIENCE
- Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
- (2020) Eli S. Rosenberg et al. ANNALS OF EPIDEMIOLOGY
- Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
- (2020) Joseph Grant et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
- (2020) Johannes Korth et al. JOURNAL OF CLINICAL VIROLOGY
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
- (2020) Silvia Stringhini et al. LANCET
- Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
- (2020) Javier Perez-Saez et al. LANCET INFECTIOUS DISEASES
- Clinical and virological data of the first cases of COVID-19 in Europe: a case series
- (2020) Francois-Xavier Lescure et al. LANCET INFECTIOUS DISEASES
- Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
- (2020) Xin Xu et al. NATURE MEDICINE
- Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
- (2020) Mariângela F. Silveira et al. NATURE MEDICINE
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- (2020) Corine H. GeurtsvanKessel et al. Nature Communications
- Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
- (2020) Alberto L. Garcia-Basteiro et al. Nature Communications
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
- (2020) Fiona P. Havers et al. JAMA Internal Medicine
- SARS-CoV-2 serosurvey in health care workers of the Veneto Region
- (2020) Mario Plebani et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset
- (2020) Patrícia Figueiredo‐Campos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
- (2020) Vivek Naranbhai et al. JOURNAL OF INFECTIOUS DISEASES
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bioluminescence Profiling of NanoKAZ/NanoLuc Luciferase Using a Chemical Library of Coelenterazine Analogues
- (2019) Eloi P Coutant et al. CHEMISTRY-A EUROPEAN JOURNAL
- Luminescence enhancement of the catalytic 19kDa protein (KAZ) of Oplophorus luciferase by three amino acid substitutions
- (2014) Satoshi Inouye et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started